Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Dampening Down Neurotransmission to Sharpen Vision in Aging Monkeys?
1 May 2003. Counterintuitive as it may seem, in tomorrow's Science researchers report that the inhibitory neurotransmitter ã-aminobutyric acid (GABA) can temporarily restore age-related losses of visual acuity in monkeys.

Audie Leventhal, University of Utah, Salt Lake City, together with colleagues in Hefei and Kunming, China, tested GABA, and its agonists and antagonists, on neurons in area VI of the visual cortex. These neurons respond to specific orientations and direction of motion of objects in the visual field, but their function declines with age, which may explain why older animals perform poorly in visual tests.

Leventhal had previously reported that area VI neurons in very old monkeys (26 to 30 years old) have decreased signal-to-noise ratios and poorly discern orientation and directional movement. They are also much more likely to fire spontaneously, suggesting that their inhibitory modulation is defective. In this study, the authors tested individual area VI neurons from both old and young animals. When the researchers measured electrical activity in untreated neurons from old animals, the cells responded equally well to stimuli from any orientation, suggesting they had lost directional selectivity, whereas young neurons responded only to stimuli in specific locations of the visual field. By contrast, when Leventhal added GABA to the old neurons, they regained directional selectivity within minutes. Moreover, they improved their signal-to-noise ratio and reduced spontaneous firing, approaching levels typical of their young counterparts. The GABA agonist muscimol elicited an even better signal-to-noise ratio than did GABA. The neurons reverted to their original performance equally rapidly after drug withdrawal.

The GABA antagonist bicuculline reversed the effect of GABA on old neurons, and it abolished directional selectivity in young neurons. The latter finding suggests that there may be a basal level of GABA activity in area VI that is absent in older cortices. GABA and muscimol had strong effects on older neurons, reducing spontaneous firing by 58 and 83 percent, respectively, vs. reductions in young neurons of only 11 and 9 percent, respectively.

While this research was limited strictly to individual neurons in the visual cortex, its implications may be broad and "important for the treatment of the sensory, motor, and cognitive declines that accompany old age," according to the authors.-Tom Fagan.

Reference:
Leventhal G, Wang Y, Pu M, Zhou Y, Ma Y. GABA and its agonists improved visual cortical function in senescent monkeys. Science 2003 May 2;300:812-815. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad